ALXN News and Press, Alexion Pharmaceuticals Inc. From 07/15/21

Zhanna Hapanovich/iStock via Getty Images After the U.K. Competition and Markets Authority greenlighted the proposed acquisition of Alexion Pharmaceuticals (ALXN) by AstraZeneca (AZN), the deal is expected to close on July 21 after which Alexion shares will be delisted from Nasdaq, the exchan...

NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Honeywell International Inc. (Nasdaq: HON), will become a component of the NASDAQ-100 Index ® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the NASDAQ-100 Ex-Technology In...

Roland Magnusson/iStock Editorial via Getty Images AstraZeneca's (AZN) planned $39B acquisition of Alexion (ALXN) has been approved by the U.K.'s Competition and Markets Authority ("CMA"), according to the regulator's website. The antitrust regulator began its inquiry in late May. On May 11, ...

Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...

Roland Magnusson/iStock Editorial via Getty Images AstraZeneca (AZN) has received the clearance from the European Commission for its proposed acquisition of rare disease specialist Alexion Pharmaceuticals (ALXN). The deal valued at $39B was previously cleared in the U.S., Japan, and several o...

Jeremy Grantham’s 13F portfolio value increased from $16.28B to $18.31B this quarter. GMO Capital added Global Payments and increased Baidu and Cigna while decreasing Raytheon Technologies and NetEase. The largest three individual stock positions are Microsoft Corporation, ...

Inflation is here; and that means these groups ought to be on your radar. The best stocks within every sector now. Over 20 new stocks join our 'best stocks' list this week. For further details see: The Stocks To Focus On Today

- Exploratory biomarker analyses suggest possible cardiac disease improvements and renal response - Caelum Biosciences and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced new Phase 2 safety and tolerability data for CAEL-101, a potentially first-in-class amyl...

– With this approval, ULTOMIRIS is the first and only medicine approved in the U.S. to treat children and adolescents with PNH – – Approval based on interim results from Phase 3 study showing ULTOMIRIS demonstrated complete terminal complement inhibition t...

Penny Stocks To Watch For June Trading penny stocks is something that millions of people do daily. But it’s isn’t something that everyone has been able to master. Best-known for their high-flying moves in price, the “land of cheap stocks” is more frequently c...